What to expect from drug discovery and development in 2023
Drug Discovery World
JANUARY 26, 2023
The modernisation of R&D models could be key to reducing spend on new drugs, a point that Deloitte makes about the need to transform the clinical trials process. At the height of the pandemic, DCTs were seen as a viable alternative to keeping the engines running on clinical trials when non-critical in-person care was paused.
98 
Let's personalize your content